US Patent Issued to REGiMMUNE, Osaka University on April 14 for "CD1d-ligand-compound-containing liposome preparation having improved pharmacokinetics" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,559, issued on April 14, was assigned to REGiMMUNE Corp. (Tokyo) and Osaka University (Suita, Japan).

"CD1d-ligand-compound-containing liposome preparation having improved pharmacokinetics" was invented by Yasuyuki Ishii (Tokyo) and Takashi Matsuzaki (Suita, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a liposome preparation containing a population of liposomes containing a CD1d ligand compound, wherein the average particle size of the population of liposomes is 90 to 110 nm and the polydispersity index of particle size distribution is 0.2 or less. and the polydispersity index of the particle size distribution...